Sector
PharmaceuticalsOpen
₹71.49Prev. Close
₹70.09Turnover(Lac.)
₹3.51Day's High
₹72.5Day's Low
₹7152 Week's High
₹86.8552 Week's Low
₹35.1Book Value
₹2.1Face Value
₹1Mkt Cap (₹ Cr.)
338.33P/E
35.23EPS
2.03Divi. Yield
020 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
5 Dec 2024
12:00 AM
AGM
Announcement Date: 05 Dec, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 4.73 | 4.73 | 4.73 | 4.73 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -4.4 | 0.73 | 10.16 | 13.71 |
Net Worth | 0.33 | 5.46 | 14.89 | 18.44 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 132.71 | 106.28 | 1.46 | 0.19 |
yoy growth (%) | 24.86 | 7,179.88 | 660 | -89 |
Raw materials | -96.85 | -80.24 | -0.35 | -0.08 |
As % of sales | 72.97 | 75.5 | 24.24 | 42.54 |
Employee costs | -14.09 | -10.8 | -0.83 | -2.13 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | 5.53 | 1.22 | -1 | -4.04 |
Depreciation | -1.91 | -1.66 | -0.34 | -0.29 |
Tax paid | -0.43 | 0.15 | 0.07 | 0 |
Working capital | 5.9 | 31.91 | -0.32 | 1.93 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 24.86 | 7,179.88 | 660 | -89 |
Op profit growth | 88.23 | -553.78 | -70.97 | 76.22 |
EBIT growth | 137.67 | -609.74 | -78.87 | 110.41 |
Net profit growth | 269.61 | -248.57 | -77.06 | 138.02 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.25 | 95.58 | 4,08,666.73 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,785.4 | 81.57 | 1,80,131.05 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,482.45 | 24.88 | 1,19,745.08 | 1,485.4 | 1.08 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,504.35 | 62.68 | 1,18,597.8 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,640.6 | 57.84 | 1,08,985.15 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
CMD & CEO
Sameer Goel
Independent Director
Jagdeep Dhavvan
Independent Director
Richa Gupta
Non Executive Director
Vipul Goel
Company Sec. & Compli. Officer
Pallavi Garg
Director (Technical)
RAMAKRISHNAVARA PRASADA RAJU MANTENA
Bhondsi Village,
Tehsil Sohna,
Haryana - 122102
Tel: 91-11-29535650
Website: http://www.kimiabiosciences.com
Email: compliance.kimia@gmail.com
Beetal House 3rd Flr,
Behind Local Shp Cen, Nr Dada Harsukh Das,
New Delhi - 110062
Tel: 91-11-29961281-82
Website: www.beetalfinancial.com
Email: beetal@beetalfinancial.com
Summary
Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal....
Read More
Reports by Kimia Biosciences Ltd
What is the Kimia Biosciences Ltd share price today?
What is the Market Cap of Kimia Biosciences Ltd?
What is the PE and PB ratio of Kimia Biosciences Ltd?
What is the 52 Week High and Low of Kimia Biosciences Ltd?
What is the CAGR of Kimia Biosciences Ltd?
What is the shareholding pattern of Kimia Biosciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.